Skip to main content
. 2020 May;12(5):2963–2970. doi: 10.21037/jtd.2020.02.10

Table 4. In-hospital mortality and hospital length of stay analyzed by change in tricuspid regurgitation severity after transcatheter aortic valve replacement.

Variable Change in tricuspid regurgitation severity P value
Remained milda (N=115) Improvedb (N=30) No change/worsenedc (N=29)
All-cause mortality 4/115 (3.5) 3/30 (10.0) 6/28 (21.4) 0.002
Cardiovascular mortality 2/115(1.7) 2/30 (6.7) 4/29 (13.8) 0.005
Median length of hospital stay (days, IQR) 5 [3–10] 4.5 [4–8] 7 [4–20] 0.241

Variables presented as number (percentage), unless otherwise noted. a, patients with trace/mild tricuspid regurgitation before TAVR and after TAVR; b, patients with moderate or severe tricuspid regurgitation that improved by 1 or more grades after TAVR; c, patients with baseline and post-TAVR persistent moderate or severe tricuspid regurgitation. IQR, interquartile range; TAVR, transcatheter aortic valve replacement.